BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16763974)

  • 1. Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?
    Gronchi-Perrin A; Viollier S; Ghika J; Combremont P; Villemure JG; Bogousslavsky J; Burkhard PR; Vingerhoets F
    Mov Disord; 2006 Sep; 21(9):1465-8. PubMed ID: 16763974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
    Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E
    Mov Disord; 2007 May; 22(7):990-7. PubMed ID: 17443692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease.
    Erola T; Heikkinen ER; Haapaniemi T; Tuominen J; Juolasmaa A; Myllylä VV
    Acta Neurochir (Wien); 2006 Apr; 148(4):389-94. PubMed ID: 16284705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.
    Volkmann J; Albanese A; Kulisevsky J; Tornqvist AL; Houeto JL; Pidoux B; Bonnet AM; Mendes A; Benabid AL; Fraix V; Van Blercom N; Xie J; Obeso J; Rodriguez-Oroz MC; Guridi J; Schnitzler A; Timmermann L; Gironell AA; Molet J; Pascual-Sedano B; Rehncrona S; Moro E; Lang AC; Lozano AM; Bentivoglio AR; Scerrati M; Contarino MF; Romito L; Janssens M; Agid Y
    Mov Disord; 2009 Jun; 24(8):1154-61. PubMed ID: 19412954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.
    Mercado R; Constantoyannis C; Mandat T; Kumar A; Schulzer M; Stoessl AJ; Honey CR
    Mov Disord; 2006 Sep; 21(9):1457-61. PubMed ID: 16721750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease.
    Nazzaro JM; Pahwa R; Lyons KE
    Parkinsonism Relat Disord; 2011 Sep; 17(8):606-9. PubMed ID: 21669545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apraxia of eyelid opening after subthalamic deep brain stimulation may be caused by reduction of levodopa.
    Umemura A; Toyoda T; Yamamoto K; Oka Y; Ishii F; Yamada K
    Parkinsonism Relat Disord; 2008 Dec; 14(8):655-7. PubMed ID: 18316231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus.
    Østergaard K; Aa Sunde N
    Mov Disord; 2006 May; 21(5):624-31. PubMed ID: 16283616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic nucleus stimulation applied in the earlier vs. advanced stage of Parkinson's disease - retrospective evaluation of postoperative independence in pursuing daily activities.
    Yamada K; Hamasaki T; Kuratsu J
    Parkinsonism Relat Disord; 2009 Dec; 15(10):746-51. PubMed ID: 19481492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
    Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of unexpected long-term improvement of Parkinson's disease after subthalamic nucleus deep brain stimulation removal.
    Wong SH; Eldridge PR; Duffy A; Fox SH; Varma TR; Fletcher NA
    Br J Neurosurg; 2011 Apr; 25(2):281-3. PubMed ID: 21344961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
    Lyons KE; Davis JT; Pahwa R
    Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
    Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long-term follow-up.
    Tavella A; Bergamasco B; Bosticco E; Lanotte M; Perozzo P; Rizzone M; Torre E; Lopiano L
    Neurol Sci; 2002 Sep; 23 Suppl 2():S111-2. PubMed ID: 12548368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease.
    Siderowf A; Jaggi JL; Xie SX; Loveland-Jones C; Leng L; Hurtig H; Colcher A; Stern M; Chou KL; Liang G; Maccarone H; Simuni T; Baltuch G
    Mov Disord; 2006 Jun; 21(6):746-53. PubMed ID: 16463342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEP latency shift after implantation of deep brain stimulation systems in the subthalamic nucleus in patients with advanced Parkinson's disease.
    Hidding U; Bäumer T; Siebner HR; Demiralay C; Buhmann C; Weyh T; Moll C; Hamel W; Münchau A
    Mov Disord; 2006 Sep; 21(9):1471-6. PubMed ID: 16703590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.
    Wider C; Russmann H; Villemure JG; Robert B; Bogousslavsky J; Burkhard PR; Vingerhoets FJ
    Arch Neurol; 2006 Jul; 63(7):951-5. PubMed ID: 16831963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.